Avion Wealth Cytokinetics Inc Transaction History
Avion Wealth
- $466 Million
- Q3 2025
A detailed history of Avion Wealth transactions in Cytokinetics Inc stock. As of the latest transaction made, Avion Wealth holds 36 shares of CYTK stock, worth $2,161. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36
Previous 12
200.0%
Holding current value
$2,161
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYTK
# of Institutions
385Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.06 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$881 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$719 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$470 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$383 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.65B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...